EUVIMEDEUVIMED entdecken
Crossref

Evaluation of neutrophil HDL-C ratio — a new inflammation marker in non-alcoholic fatty liver disease

Enver Avcı iD, Mine Ozturk iD

Endokrynologia Polska · 2023

DOI: 10.5603/ep.96715 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endokrynologia Polska, 2023. Verfasst von Enver Avcı und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Medova Hospital, Konya, Türkiye. enver.a.dr@gmail.com. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseMaleHumansFemaleAdolescentYoung AdultAdultMiddle AgedAgedRisk FactorsNeutrophilsInflammationCholesterol, HDLFibrosis

Stichwörter der Autor:innen

FIB-4NAFLDNHR

Substanzen

Cholesterol, HDL

Autor:innen und Institutionen

  • Department of Gastroenterology, Medova Hospital, Konya, Türkiye. enver.a.dr@gmail.com.
  • Department of Endocrinology, Konya City Hospital, Konya, Türkiye.

ORCID-Profile: Enver Avcı, Mine Ozturk

Zitieren

APA

Avcı, E., & Ozturk, M. (2023). Evaluation of neutrophil HDL-C ratio — a new inflammation marker in non-alcoholic fatty liver disease. Endokrynologia Polska. https://doi.org/10.5603/ep.96715

Vancouver

Avcı E, Ozturk M. Evaluation of neutrophil HDL-C ratio — a new inflammation marker in non-alcoholic fatty liver disease. Endokrynologia Polska. 2023. doi:10.5603/ep.96715

BibTeX
@article{Avc2023,
  author = {Avcı, Enver and Ozturk, Mine},
  title = {Evaluation of neutrophil HDL-C ratio — a new inflammation marker in non-alcoholic fatty liver disease},
  journal = {Endokrynologia Polska},
  year = {2023},
  doi = {10.5603/ep.96715}
}
Kostenlos starten →